Abstract
IgA nephropathy is one of the most common cause of chronic glomerulonephritis, however there is no specific method of treatment however we have been tried methylprednisolone pulse therapy in early stage IgA nephropathy since 1984 and reported a promising result at “New therapeutic strategies in nephrology” meeting which was held at Sorrento in 1990, however this therapy was not so effective in CKD with IgAN. Cell based therapy is an emerging field in nephrology especially adipose derived stem cells (ASCs). We tried MP pulse therapy and SVF in CKD with IgAN.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
